Advanced search
Publication Cover
Leukemia & Lymphoma Volume 31, 1998 - Issue 3-4
Submit an article Journal homepage
34
Views
41
CrossRef citations to date
0
Altmetric
Original Article

A Phase II Study of Interleukin-2 in 49 Patients with Relapsed or Refractory Acute Leukemia

Dominique Maraninchi Institut Paoli-Calmettes, INSERM, Unit 119, Marseille, France
,
Norbert Vey Institut Paoli-Calmettes, INSERM, Unit 119, Marseille, France
,
Patrice Viens Institut Paoli-Calmettes, INSERM, Unit 119, Marseille, France
,
Anne-Marie Stoppa Institut Paoli-Calmettes, INSERM, Unit 119, Marseille, France
,
Eric Archimbaud CHU Edouard Herriot, Lyon, France
,
Michel Attal CHU Purpan Toulouse, France
,
Daniel Baume Institut Paoli-Calmettes, INSERM, Unit 119, Marseille, France
,
Reda Bouabdallah Institut Paoli-Calmettes, INSERM, Unit 119, Marseille, France
,
Francois Demeoq CHU Clermont-Ferrand, France
,
Joel Fleury CHU Clermont-Ferrand, France
,
Mauricette Michallet CHU Grenoble, France
,
Daniel Olive Institut Paoli-Calmettes, INSERM, Unit 119, Marseille, France
,
Josy Reiffers CHU Haut Leveque, Bordeaux, France
,
Daniele Sainty Institut Paoli-Calmettes, INSERM, Unit 119, Marseille, France
,
Antonio Tabilio Clinica Ematologica, Universita di Perugia, Perugia, Italy
,
Pierre Tiberghien CHU Jean Minjoz, Besancon, France
,
Maud Brandely Institut Paoli-Calmettes, INSERM, Unit 119, Marseille, France
,
Thierry Hercend Institut Paoli-Calmettes, INSERM, Unit 119, Marseille, France
&
Didier Blaise Roussel-UCLAFRomainville, FranceCorrespondence[email protected]
 show all
Pages 343-349 | Received 01 Jan 1998, Published online: 01 Jul 2009

Citations (41)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Armin Rashidi & Stephen I. Fisher. (2015) Spontaneous remission of acute myeloid leukemia. Leukemia & Lymphoma 56:6, pages 1727-1734.
Read now
S Derzic, V Slone & L Sender. (2005) IL-2-activated cord blood mononuclear cells. Cytotherapy 7:5, pages 408-416.
Read now

Articles from other publishers (39)

Qiang Zeng, Bing Xiang & Zhigang Liu. (2022) Autologous hematopoietic stem cell transplantation followed by interleukin-2 for adult acute myeloid leukemia patients with favorable or intermediate risk after complete remission. Annals of Hematology 101:8, pages 1711-1718.
Crossref
Omid Karimdadi Sariani, Sara Eghbalpour, Elahe Kazemi, Kimia Rafiei Buzhani & Farhad Zaker. (2021) Pathogenic and therapeutic roles of cytokines in acute myeloid leukemia. Cytokine 142, pages 155508.
Crossref
HassnienSamir Al-Hashemi, SabahA. Hameid A. Rahman & ZeyadAhmed Shabeeb. (2021) Expression of immune checkpoint molecules in Iraqi acute myeloid leukemia patients. Iraqi Journal of Hematology 10:1, pages 1.
Crossref
Heike E. Daldrup-Link. 2021. Molecular Imaging. Molecular Imaging 1131 1147 .
Benjamin L. Franc & Heike Elisabeth Daldrup-Link. 2019. Imaging in Pediatric Oncology. Imaging in Pediatric Oncology 347 367 .
Arnaud Petit, Stéphane Ducassou, Thierry Leblanc, Marlène Pasquet, Alexandra Rousseau, Christine Ragu, Marine Cachanado, Brigitte Nelken, Yves Bertrand, Gérard Michel, Virginie Gandemer, Wendy Cuccuini, Odile Fenneteau, Hélène Lapillonne, Anne Auvrignon, André Baruchel & Guy Leverger. (2018) Maintenance Therapy With Interleukin-2 for Childhood AML. HemaSphere 2:6, pages e159.
Crossref
Cristina Bergamaschi, Dionysios C. Watson, Antonio Valentin, Jenifer Bear, Cody J. Peer, William D. FiggSr.Sr., Barbara K. Felber & George N. Pavlakis. (2018) Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques. Cytokine 108, pages 213-224.
Crossref
Jonathan Canaani & Selina M. Luger. (2016) Revisiting maintenance therapy in acute myeloid leukemia with novel agents. Current Opinion in Hematology 23:2, pages 175-180.
Crossref
Chen Mao, Xiao-Hong Fu, Jin-Qiu Yuan, Zu-Yao Yang, Ya-Fang Huang, Qian-Ling YE, Xin-Yin Wu, Xue-Feng Hu, Zhi-Min Zhai & Jin-Ling Tang. (2015) Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission. Cochrane Database of Systematic Reviews 2015:11.
Crossref
Peter H. Wiernik. (2014) Optimal Therapy for Adult Patients with Acute Myeloid Leukemia in First Complete Remission. Current Treatment Options in Oncology 15:2, pages 171-186.
Crossref
Heike Elisabeth Daldrup-Link & Sanjiv Sam Gambhir. 2014. Pediatric Nuclear Medicine and Molecular Imaging. Pediatric Nuclear Medicine and Molecular Imaging 571 595 .
Peter H. Wiernik. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 375 401 .
Chen Mao, Ya-Fang Huang, Zu-Yao Yang, Qian-Ling YE, Xin-Yin Wu, Xue-Feng Hu, Zhi-Min Zhai & Jin Ling Tang. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Elisa Ferretti, Claudia Cocco, Irma Airoldi & Vito Pistoia. (2012) Targeting acute myeloid leukemia cells with cytokines. Journal of Leukocyte Biology 92:3, pages 567-575.
Crossref
Marc BuysePierre SquiffletBeverly J. LangeTodd A. AlonzoRichard A. LarsonJonathan E. KolitzStephen L. GeorgeClara D. BloomfieldSylvie CastaigneSylvie ChevretDidier Blaise, Dominique Maraninchi, Kathryn J. Lucchesi & Tomasz Burzykowski. (2011) Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia. Blood 117:26, pages 7007-7013.
Crossref
A. I. Romero, F. B. Thorén, J. Aurelius, G. Askarieh, M. Brune & K. Hellstrand. (2009) Post-consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML. Scandinavian Journal of Immunology 70:3, pages 194-205.
Crossref
Wendy Ingram, Lucas Chan, Hayrettin Guven, David Darling, Shahram Kordasti, Nicola Hardwick, Linda Barber, Ghulam J. Mufti & Farzin Farzaneh. (2009) Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study. British Journal of Haematology 145:6, pages 749-760.
Crossref
Evelien L.J.M. Smits, Zwi N. Berneman & Viggo F.I. Van Tendeloo. (2009) Immunotherapy of Acute Myeloid Leukemia: Current Approaches. The Oncologist 14:3, pages 240-252.
Crossref
Gheath Alatrash & Jeffrey J. Molldrem. 2010. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia 237 255 .
Maria R. Baer, Stephen L. George, Michael A. Caligiuri, Ben L. Sanford, Sandra M. Bothun, Krzysztof Mrózek, Jonathan E. Kolitz, Bayard L. Powell, Joseph O. Moore, Richard M. Stone, John Anastasi, Clara D. Bloomfield & Richard A. Larson. (2008) Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720. Journal of Clinical Oncology 26:30, pages 4934-4939.
Crossref
Richard M. Stone, Daniel J. DeAngelo, Anna Janosova, Ilene Galinsky, Christine Canning, Jerome Ritz & Robert J. Soiffer. (2008) Low dose interleukin‐2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission. American Journal of Hematology 83:10, pages 771-777.
Crossref
Reinhard Meier, Morand Piert, Guido Piontek, Martina Rudelius, Robert A. Oostendorp, Reingard Senekowitsch-Schmidtke, Tobias D. Henning, Winfried S. Wels, Christoph Uherek, Ernst J. Rummeny & Heike E. Daldrup-Link. (2008) Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors. Nuclear Medicine and Biology 35:5, pages 579-588.
Crossref
K R Meehan, J Wu, E Bengtson, J Hill, P Ely, Z Szczepiorkowski, M Kendall & M S Ernstoff. (2007) Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma. Bone Marrow Transplantation 39:11, pages 695-703.
Crossref
Hisaki FujiiJacqueline D. TrudeauDavid T. Teachey, Jonathan D. Fish, Stephan A. Grupp, Kirk R. SchultzGregor S. D. Reid. (2006) In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides. Blood 109:5, pages 2008-2013.
Crossref
Sherif S. Farag & Michael A. Caligiuri. (2006) Immunologic Approaches to Acute Leukemia in the Elderly. Seminars in Hematology 43:2, pages 118-125.
Crossref
Torsten Tonn & Erhard Seifried. (2006) Natural Killer Cells for the Treatment of Malignancies*. Transfusion Medicine and Hemotherapy 33:2, pages 144-149.
Crossref
Anne-Marie Stoppa, Norbert Vey, Reda Bouabdallah, Catherine Faucher, Régis Costello, Diane Coso, Danielle Sainty, Christine Arnoulet, Marina Lafage, Marie-Joelle Mozziconacci, Didier Blaise, Jean-Albert Gastaut & Dominique Maraninchi. (2006) Pronostic et traitement des leucémies aiguës myéloblastiques. EMC - Hématologie 1:1, pages 1-13.
Crossref
Marie Robin, Marie-Hélène Schlageter, Christine Chomienne & Rose-Ann Padua. (2005) Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans. Cancer Immunology, Immunotherapy 54:10, pages 933-943.
Crossref
Heike E. Daldrup-Link, Reinhardt Meier, Martina Rudelius, Guido Piontek, Morand Piert, Stephan Metz, Marcus Settles, Christoph Uherek, Winfried Wels, J�rgen Schlegel & Ernst J. Rummeny. (2004) In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. European Radiology 15:1, pages 4-13.
Crossref
K. Hübel, J. Chemnitz, H.-G. Brochhagen & O. A. Cornelya. (2004) Successful Treatment of Chronic Disseminated Candidiasis with Caspofungin and Itraconazole in a Patient with Progressive Acute Leukemia and Prolonged Neutropenia. International Journal of Hematology 79:3, pages 289-292.
Crossref
Sherif S. Farag & Michael A. Caligiuri. 2004. Treatment of Leukemia and Lymphoma. Treatment of Leukemia and Lymphoma 295 318 .
Wolfgang Hiddemann, Heinz Huber & Claus R. BartramW. Kern, T. Haferlach & W. Hiddemann. 2004. Die Onkologie. Die Onkologie 1847 1915 .
Ulrike Reiss & Ellen Bolotin. (2002) New approaches to hematopoietic cell transplantation in oncology. Pediatric Clinics of North America 49:6, pages 1437-1466.
Crossref
Mark J. Smyth, Yoshihiro Hayakawa, Kazuyoshi Takeda & Hideo Yagita. (2002) New aspects of natural-killer-cell surveillance and therapy of cancer. Nature Reviews Cancer 2:11, pages 850-861.
Crossref
Christoph UherekTorsten TonnBarbara UherekSven BeckerBarbara SchnierleHans-Georg KlingemannWinfried Wels. (2002) Retargeting of natural killer–cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction. Blood 100:4, pages 1265-1273.
Crossref
Edward A Stadtmauer. (2002) Histamine dihydrochloride and interleukin-2 in the treatment of acute myeloid leukemia. Seminars in Oncology 29:3, pages 47-51.
Crossref
G. Mathé & J.L. Amiel. (2001) The roles of adoptive and active forms of immunotherapy in the cure of children suffering from acute lymphoid leukemia: a) underestimation of active immunotherapy benefit, b) its immunogenetic indications to select sensitive patients, hence prevent chemotherapy’s late effects. Biomedicine & Pharmacotherapy 55:9-10, pages 531-542.
Crossref
Torsten Tonn, Sven Becker, Ruth EsserDirk SchwabeErhard Seifried. (2001) Cellular Immunotherapy of Malignancies Using the Clonal Natural Killer Cell Line NK-92. Journal of Hematotherapy & Stem Cell Research 10:4, pages 535-544.
Crossref
Guillermo Garcia-Manero & Deborah A. Thomas. (2001) Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia. Hematology/Oncology Clinics of North America 15:1, pages 163-205.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.